Abstract
Current studies concerning myotonic dystrophy type 1 (DM1) are in the process of transitioning from molecular investigations to preclinical and clinical trials
Keywords
Funding Information
  • National Institutes of Health (5RO1NS115662, 5RO1AR073379)
  • CCHMC (5RO1NS115662, 5RO1AR073379)

This publication has 20 references indexed in Scilit: